JP6522509B2 - 皮膚、毛髪および／または粘膜の処置および／またはケアにおいて有用な化合物ならびにそれらの化粧品組成物または医薬組成物 - Google Patents

皮膚、毛髪および／または粘膜の処置および／またはケアにおいて有用な化合物ならびにそれらの化粧品組成物または医薬組成物 Download PDF

Info

Publication number
JP6522509B2
JP6522509B2 JP2015545782A JP2015545782A JP6522509B2 JP 6522509 B2 JP6522509 B2 JP 6522509B2 JP 2015545782 A JP2015545782 A JP 2015545782A JP 2015545782 A JP2015545782 A JP 2015545782A JP 6522509 B2 JP6522509 B2 JP 6522509B2
Authority
JP
Japan
Prior art keywords
inci
agents
agent
pharmaceutically acceptable
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015545782A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016502550A5 (enExample
JP2016502550A (ja
Inventor
デン ネスト， ウィム バン
デン ネスト， ウィム バン
セライマ クリスティーナ カレーニョ，
セライマ クリスティーナ カレーニョ，
ゴンサレス， ラケル デルガド
ゴンサレス， ラケル デルガド
モンティエル， アントニオ ビセンテ フェレール
モンティエル， アントニオ ビセンテ フェレール
Original Assignee
ルブリゾル アドバンスド マテリアルズ， インコーポレイテッド
ルブリゾル アドバンスド マテリアルズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ルブリゾル アドバンスド マテリアルズ， インコーポレイテッド, ルブリゾル アドバンスド マテリアルズ， インコーポレイテッド filed Critical ルブリゾル アドバンスド マテリアルズ， インコーポレイテッド
Publication of JP2016502550A publication Critical patent/JP2016502550A/ja
Publication of JP2016502550A5 publication Critical patent/JP2016502550A5/ja
Application granted granted Critical
Publication of JP6522509B2 publication Critical patent/JP6522509B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/002—Preparations for repairing the hair, e.g. hair cure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
JP2015545782A 2012-12-05 2013-12-03 皮膚、毛髪および／または粘膜の処置および／またはケアにおいて有用な化合物ならびにそれらの化粧品組成物または医薬組成物 Active JP6522509B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12382484.9A EP2740484A1 (en) 2012-12-05 2012-12-05 Compounds useful in the treatment and/or care of the skin, hair and/or muccous membranes and their cosmetic or pharmaceutical compositions
EP12382484.9 2012-12-05
PCT/EP2013/075401 WO2014086785A1 (en) 2012-12-05 2013-12-03 Compounds useful in the treatent and/or care of the skin, hair and/or mucous membranes and their cosmetic or pharmaceutical compositions

Publications (3)

Publication Number Publication Date
JP2016502550A JP2016502550A (ja) 2016-01-28
JP2016502550A5 JP2016502550A5 (enExample) 2017-01-19
JP6522509B2 true JP6522509B2 (ja) 2019-05-29

Family

ID=47749596

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015545782A Active JP6522509B2 (ja) 2012-12-05 2013-12-03 皮膚、毛髪および／または粘膜の処置および／またはケアにおいて有用な化合物ならびにそれらの化粧品組成物または医薬組成物

Country Status (11)

Country Link
US (1) US9511010B2 (enExample)
EP (2) EP2740484A1 (enExample)
JP (1) JP6522509B2 (enExample)
KR (1) KR102285933B1 (enExample)
CN (1) CN104968360B (enExample)
AU (1) AU2013354184C1 (enExample)
BR (1) BR112015012565B1 (enExample)
CA (1) CA2892905C (enExample)
ES (1) ES2869180T3 (enExample)
PL (1) PL2928484T3 (enExample)
WO (1) WO2014086785A1 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2792684A1 (en) * 2013-04-15 2014-10-22 Lipotec, S.A. Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions
WO2015066647A2 (en) 2013-11-03 2015-05-07 The Regents Of The University Of California Ionic liquids for transdermal drug delivery
EP2990027A1 (en) * 2014-09-01 2016-03-02 Institut Curie Skin whitening peptide agents
US10242871B2 (en) * 2014-10-21 2019-03-26 Nissan Chemical Industries, Ltd. Resist underlayer film-forming composition including a compound having an amino group protected with a tert-butoxycarbonyl group
KR102481341B1 (ko) 2014-10-31 2022-12-23 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 피부 표면으로 활성 작용제의 전달을 위한 열가소성 폴리우레탄 필름
WO2016077817A1 (en) * 2014-11-14 2016-05-19 The General Hospital Corporation Methods and compositions for enhancing skin pigmentation
CN104523449A (zh) * 2015-01-08 2015-04-22 上海圣婕化妆品有限公司 一种抗衰老多胜肽复合物及其应用
CN104622779A (zh) * 2015-01-08 2015-05-20 上海圣婕化妆品有限公司 一种多胜肽抗衰老修复面膜精华液及其制备方法
US10722436B2 (en) 2015-08-10 2020-07-28 Mary Kay Inc. Topical compositions
WO2017079248A1 (en) 2015-11-05 2017-05-11 Lubrizol Advanced Materials, Inc. Thermoformable dual network hydrogel compositions
CN105362088B (zh) * 2015-12-22 2019-05-17 深圳市维琪医药研发有限公司 一种用于美白亮肤淡斑的多肽组合物
JP6808908B2 (ja) * 2016-01-19 2021-01-06 ポーラ化成工業株式会社 ジェル状化粧料
HK1257429A1 (zh) 2016-02-04 2019-10-18 ALASTIN Skincare, Inc. 用於侵入性和非侵入性程序性护肤的组合物和方法
KR101671812B1 (ko) * 2016-04-28 2016-11-02 주식회사 엘지생활건강 리퀴리틴을 유효성분으로 포함하는 체모 성장 억제용 조성물
CN106176274B (zh) * 2016-08-26 2020-04-10 深圳市维琪医药研发有限公司 一种具有抗敏作用的多肽组合物
WO2018044920A1 (en) 2016-08-29 2018-03-08 The Regents Of The University Of California Topical formulations based on ionic species for skin treatment
EP3532169A1 (en) * 2016-10-27 2019-09-04 DSM IP Assets B.V. Novel method
US10828265B2 (en) 2016-12-09 2020-11-10 The Regents Of The University Of California Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery
JP7191386B2 (ja) * 2017-02-24 2022-12-19 リポトゥルー，エセ．エレ． 化粧料に使用するためのペプチドおよび組成物
KR101971643B1 (ko) 2017-04-28 2019-04-24 주식회사 마크로케어 손상 모발 개선용 조성물 및 이의 제조방법
BR112020000123A2 (pt) * 2017-07-04 2020-07-07 Lubrizol Advanced Materials, Inc. composto, uso de um composto, composição cosmética, e, método para cuidado e/ou tratamento cosmético não terapêutico da pele, cabelos, unhas e/ou membranas mucosas
JP7340140B2 (ja) * 2017-07-20 2023-09-07 ダイヤ製薬株式会社 含水組成物、含水組成物を構成した貼付剤、化粧品又は外皮用医薬品、並びに、これらの製造方法
KR102757675B1 (ko) 2017-08-03 2025-01-20 앨러스틴 스킨케어, 인크. 피부 이완 및 신체 윤곽의 개선을 위한 조성물 및 방법
EP3761952B1 (en) * 2018-03-09 2024-08-14 Ocusoft, Inc. Topical skin care compositions
WO2020028694A1 (en) 2018-08-02 2020-02-06 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
WO2020142211A1 (en) 2019-01-02 2020-07-09 The Procter & Gamble Company Skin care compositions containing peptide compound and aphanothece sacrum exopolysaccharide extract
CN110420140B (zh) * 2019-07-16 2022-09-27 广州艾蓓生物科技有限公司 一种具有长效祛眼袋效果的祛眼袋霜及其制备方法
PL3831358T3 (pl) * 2019-12-04 2025-08-04 Lipotrue, S.L. Peptydy i kompozycje do stosowania w kosmetyce i medycynie
CN111358991B (zh) * 2020-03-24 2021-12-21 福建省海乐威生物工程有限公司 一种鞋袜除臭抗菌组合物及其制备方法
CN111632018B (zh) * 2020-06-12 2022-05-27 广东芭薇生物科技股份有限公司 一种含水解藻提取物的组合物及其应用
US20220110852A1 (en) * 2020-10-14 2022-04-14 Chanda Zaveri Pigment Stabilizers
US11771637B2 (en) 2021-01-22 2023-10-03 The Procter & Gamble Company Skin care composition and method of using the same
US11571378B2 (en) 2021-01-22 2023-02-07 The Procter & Gamble Company Skin care composition and method of using the same
BR102021015486A2 (pt) * 2021-08-05 2023-02-14 Aché Laboratórios Farmacêuticos S.A. Composição de nanopartícula lipídica contendo extrato de vitis vinifera, usos cosméticos de uma composição de nanopartícula lipídica contendo extrato de vitis vinifera, produto dermocosmético antioxidante e para prevenir o envelhecimento da pele e método de cuidado da pele
CN117659124A (zh) * 2021-11-25 2024-03-08 暨南大学 一类促进组织修复的新多肽及其应用
CN115364028B (zh) * 2022-09-19 2023-06-13 广州诺德丽诗化妆品有限公司 一种生物肽赋活修护面膜液及其制备方法
CN115581633B (zh) * 2022-10-14 2023-09-12 深圳市维琪科技股份有限公司 肽类化合物在制备用于皮肤延衰修复的组合物中的新用途
CN115804745B (zh) * 2022-12-27 2024-05-24 广州天然国度生物科技有限公司 一种皮肤护理舒缓修护组合物及其应用
CN116115548A (zh) * 2023-02-24 2023-05-16 配方化妆品科技(广州)有限公司 一种促毛囊、毛发生长的组合物及制备方法及应用
CN116196256B (zh) * 2023-03-17 2024-12-06 二元(苏州)工业科技有限公司 含精氨酸赖氨酸多肽的促渗透组合物及其制备方法和应用
CN117137851A (zh) * 2023-06-12 2023-12-01 华陈兴 一种含有美白组分的化妆品组合物
CN116751510B (zh) * 2023-07-10 2024-06-25 阿梓萨科技(深圳)有限公司 丙烯酸树脂复合纳米纤维素的光固化涂料的制备方法
CN118203650B (zh) * 2024-01-26 2025-04-29 上海萨丽斐生物科技有限公司 一种用于治疗色素沉着的药物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090062512A1 (en) * 2000-10-10 2009-03-05 Hildebrand William H Comparative ligand mapping from MHC class I positive cells
EP1625151A2 (en) * 2003-05-13 2006-02-15 The Board Of Regents Of The University Of Oklahoma Comparative ligand mapping from mhc class i positive cells
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
US20060069049A1 (en) * 2003-12-29 2006-03-30 President And Fellows Of Harvard College Methods and reagents related to foxo
US7288385B2 (en) * 2004-06-25 2007-10-30 The Salk Institute For Biological Studies Increasing life span by modulation of Smek
DE102004031579B4 (de) * 2004-06-29 2012-12-27 Forschungsverbund Berlin E.V. Peptide zur Inhibition der Interaktion von Proteinkinase A und Proteinkinase A-Ankerproteinen, diese umfassendes Nukleinsäuremolekül, Vektor, Wirtszelle, gegen diese gerichtetes Erkennungsmolekül, diese enthaltende pharmazeutische Zusammensetzung, diese enthaltender Kit und deren Verwendung
EP1907016A2 (en) * 2005-07-11 2008-04-09 Irm, Llc Methods and composition for modulating foxo1 activity and insulin signaling
US20080107682A1 (en) * 2005-12-01 2008-05-08 Gireesh Rajashekara Brucella melitensis mutants and methods
ES2349972B1 (es) * 2009-02-16 2011-11-24 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosméticas o farmacéuticas.
ES2358829B1 (es) * 2009-10-23 2012-06-25 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cabello y su uso en composiciones cosméticas o farmacéuticas.

Also Published As

Publication number Publication date
AU2013354184C1 (en) 2019-01-31
PL2928484T3 (pl) 2021-09-20
WO2014086785A1 (en) 2014-06-12
BR112015012565A2 (pt) 2017-09-12
EP2928484B1 (en) 2021-03-24
AU2013354184A1 (en) 2015-06-11
CA2892905C (en) 2023-08-15
CN104968360B (zh) 2018-04-17
EP2928484A1 (en) 2015-10-14
EP2740484A1 (en) 2014-06-11
ES2869180T3 (es) 2021-10-25
JP2016502550A (ja) 2016-01-28
BR112015012565B1 (pt) 2021-08-31
CA2892905A1 (en) 2014-06-12
KR102285933B1 (ko) 2021-08-04
US20150342852A1 (en) 2015-12-03
AU2013354184B2 (en) 2017-12-21
CN104968360A (zh) 2015-10-07
KR20150090922A (ko) 2015-08-06
US9511010B2 (en) 2016-12-06

Similar Documents

Publication Publication Date Title
JP6522509B2 (ja) 皮膚、毛髪および／または粘膜の処置および／またはケアにおいて有用な化合物ならびにそれらの化粧品組成物または医薬組成物
CN108495646B (zh) 用于治疗和/或护理皮肤、毛发、指甲和/或粘膜的化合物
JP6470680B2 (ja) 皮膚および／または粘膜の処置および／またはケアのための組成物ならびに化粧品組成物または医薬組成物におけるその使用
EP2773366B1 (en) Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
JP6431367B2 (ja) ＰＧＣ−１αを調節するペプチド
JP7526159B2 (ja) 皮膚、毛髪、爪および／または粘膜の処置および／またはケアに有用な化合物
BR112018011643B1 (pt) Composto, composição cosmética ou farmacêutica, uso de um composto, e, método para tratamento e/ou cuidado não terapêutico e cosmético da pele, cabelo, unhas e/ou membranas mucosas

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161202

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161202

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170921

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171220

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180320

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180320

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180717

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181016

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181214

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190108

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190221

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190311

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190402

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190424

R150 Certificate of patent or registration of utility model

Ref document number: 6522509

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250